4-butyrolactone has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dünisch, P; Ewald, C; Freitag, D; Grube, S; Kalff, R; Klausnitzer, M; Sakr, Y; Walter, J | 1 |
| Bear, JE; Clemen, CS; Roadcap, DW | 1 |
1 review(s) available for 4-butyrolactone and Glioma
| Article | Year |
|---|---|
The role of mammalian coronins in development and disease.
Topics: 4-Butyrolactone; Animals; Brain Neoplasms; Gene Expression Regulation; Glioma; Humans; Mammals; Mice; Transcription, Genetic | 2008 |
1 other study(ies) available for 4-butyrolactone and Glioma
| Article | Year |
|---|---|
Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Topics: 4-Butyrolactone; Apoptosis; Autophagy; Brain; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Cerulenin; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type I; Fatty Acid Synthesis Inhibitors; Glioblastoma; Glioma; Humans; Lactones; Neoplasm Grading; Orlistat; Tissue Culture Techniques | 2014 |